A detailed history of Berkeley Capital Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 27,629 shares of MDT stock, worth $2.47 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
27,629
Previous 26,183 5.52%
Holding current value
$2.47 Million
Previous $2.28 Million 4.69%
% of portfolio
0.66%
Previous 0.7%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $113,814 - $125,830
1,446 Added 5.52%
27,629 $2.17 Million
Q1 2024

May 14, 2024

BUY
$82.84 - $88.09 $579,548 - $616,277
6,996 Added 36.46%
26,183 $2.28 Million
Q4 2023

Feb 09, 2024

BUY
$69.43 - $83.43 $55,335 - $66,493
797 Added 4.33%
19,187 $1.58 Million
Q3 2023

Nov 14, 2023

BUY
$78.22 - $90.4 $30,896 - $35,708
395 Added 2.2%
18,390 $1.44 Million
Q2 2023

Aug 03, 2023

BUY
$79.47 - $91.38 $92,582 - $106,457
1,165 Added 6.92%
17,995 $1.59 Million
Q1 2023

May 02, 2023

BUY
$76.72 - $87.58 $112,855 - $128,830
1,471 Added 9.58%
16,830 $1.36 Million
Q4 2022

Feb 10, 2023

BUY
$76.18 - $87.74 $254,669 - $293,314
3,343 Added 27.82%
15,359 $1.19 Million
Q3 2022

Nov 04, 2022

BUY
$80.75 - $95.31 $254,039 - $299,845
3,146 Added 35.47%
12,016 $970,000
Q2 2022

Aug 04, 2022

BUY
$87.4 - $113.09 $150,415 - $194,627
1,721 Added 24.07%
8,870 $796,000
Q1 2022

May 05, 2022

BUY
$100.58 - $112.38 $413,886 - $462,443
4,115 Added 135.63%
7,149 $793,000
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $102,914 - $132,093
1,034 Added 51.7%
3,034 $314,000
Q3 2021

Nov 04, 2021

BUY
$122.75 - $135.17 $12,888 - $14,192
105 Added 5.54%
2,000 $251,000
Q2 2021

Aug 16, 2021

SELL
$118.19 - $131.5 $18,201 - $20,251
-154 Reduced 7.52%
1,895 $235,000
Q4 2020

Jan 28, 2021

BUY
$100.57 - $117.14 $206,067 - $240,019
2,049 New
2,049 $240,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Berkeley Capital Partners, LLC Portfolio

Follow Berkeley Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.